WASHINGTON (Reuters) - An experimental bird flu vaccine that uses a common cold virus and bits of DNA from the H5N1 virus appears to stimulate an immune response in mice, U.S. researchers said on Thursday. They said their experiment is a first step towards developing a next-generation bird flu vaccine that does not need to be grown for months in chicken eggs and that could protect against mutated versions of the virus.
